Abstract
Infrared (IR) spectroscopy of liquid biopsies shows high potential to become a non-invasive, cost-efficient and fast diagnostic tool for several types of cancers, acute myocardial infarction, Alzheimer’s disease as well as possibly other pathologies [1]. However, interpretation of the disease-induced changes in an IR absorption spectrum remains challenging due to high molecular complexity of the samples. Here we perform for the first time Fourier-Transform IR (FTIR) absorption and non-targeted mass spectrometry (MS) based proteomic measurements of the very same set of human blood plasma samples, collected from lung cancer patients and a control group. This combination shows that the IR spectroscopic fingerprint of lung cancer is caused by differential regulation of a number of plasma proteins. Generally, quantitative analysis of cancer-induced changes in blood composition is of paramount importance for cancer diagnostics, and for improving IR spectroscopic fingerprinting approaches in particular.
© 2019 IEEE
PDF ArticleMore Like This
Marinus Huber, Liudmila Voronina, Wolfgang Schweinberger, Cristina Leonardo, Kosmas V. Kepesidis, Christina Hofer, Syed A. Hussain, Michael Trubetskov, Abdallah M. Azzeer, Ioachim Pupeza, Ferenc Krausz, and Mihaela Zigman
cl_1_3 The European Conference on Lasers and Electro-Optics (CLEO/Europe) 2019
Cristina Leonardo, Kosmas V. Kepesidis, Birgit Linkohr, Liudmila Voronina, Marinus Huber, Michael Trubetskov, Annette Peters, Christian Gieger, Ferenc Krausz, and Mihaela Zigman
jsii_p_4 European Quantum Electronics Conference (EQEC) 2019
V. Mittal, M. Nedeljkovic, A. Z. Khokhar, L. G. Carpenter, G. S. Murugan, H. M. H. Chong, P. N. Bartlett, G. Z. Mashanovich, and J. S. Wilkinson
JT4A.30 Bio-Optics: Design and Application (BODA) 2019